HK1206643A1 - Polysaccharide for use in preventing metastasis formation and or relapse - Google Patents

Polysaccharide for use in preventing metastasis formation and or relapse

Info

Publication number
HK1206643A1
HK1206643A1 HK15107429.9A HK15107429A HK1206643A1 HK 1206643 A1 HK1206643 A1 HK 1206643A1 HK 15107429 A HK15107429 A HK 15107429A HK 1206643 A1 HK1206643 A1 HK 1206643A1
Authority
HK
Hong Kong
Prior art keywords
relapse
polysaccharide
preventing metastasis
metastasis formation
formation
Prior art date
Application number
HK15107429.9A
Other languages
English (en)
Chinese (zh)
Inventor
Bernd Sundermann
Lars Walz
Silke Baasner
Frank Nocken
Christoph Meyer
Original Assignee
Fresenius Kabi De Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi De Gmbh filed Critical Fresenius Kabi De Gmbh
Publication of HK1206643A1 publication Critical patent/HK1206643A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/721—Dextrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
HK15107429.9A 2013-07-30 2015-08-03 Polysaccharide for use in preventing metastasis formation and or relapse HK1206643A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP13178566.9A EP2832360A1 (fr) 2013-07-30 2013-07-30 Polysaccharide pour utilisation dans la prévention de la formation de métastases et/ou de rechute

Publications (1)

Publication Number Publication Date
HK1206643A1 true HK1206643A1 (en) 2016-01-15

Family

ID=48900829

Family Applications (2)

Application Number Title Priority Date Filing Date
HK15107429.9A HK1206643A1 (en) 2013-07-30 2015-08-03 Polysaccharide for use in preventing metastasis formation and or relapse
HK16113882A HK1225615B (zh) 2013-07-30 2016-12-06 用於預防轉移形成和/或復發的多糖

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK16113882A HK1225615B (zh) 2013-07-30 2016-12-06 用於預防轉移形成和/或復發的多糖

Country Status (18)

Country Link
US (1) US20160175340A1 (fr)
EP (3) EP2832360A1 (fr)
KR (2) KR20160044493A (fr)
CN (1) CN105555280A (fr)
AU (1) AU2014298637B2 (fr)
CA (1) CA2918180A1 (fr)
DK (1) DK3027196T3 (fr)
ES (1) ES2628207T3 (fr)
HK (2) HK1206643A1 (fr)
HR (1) HRP20170877T1 (fr)
HU (1) HUE032564T2 (fr)
LT (1) LT3027196T (fr)
MX (1) MX348932B (fr)
PL (1) PL3027196T3 (fr)
PT (1) PT3027196T (fr)
RS (1) RS56062B1 (fr)
SI (1) SI3027196T1 (fr)
WO (1) WO2015014730A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111647096B (zh) * 2020-05-20 2021-04-06 昆明理工大学 一种中性玛咖多糖及其提取方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5616765B2 (fr) 1975-02-05 1981-04-18
DE4023788A1 (de) 1990-07-26 1992-01-30 Schumann Klaus Verwendung einer waessrigen loesung einer poly-(o-hydroxyalkyl)-staerke
US5807833A (en) 1995-06-07 1998-09-15 University Of Southern California Hydroxyethyl starch and use thereof as an absorbable mechanical barrier and intracavity carrier device
US6207654B1 (en) 1996-05-03 2001-03-27 Bashir Zikria Capillary membrane stabilization and reduction of inflammation during the course of chemotherapy or antiviral treatment through the use of biodegradable macromolecules and interleukin-2
CA2496508C (fr) 2002-09-04 2014-04-22 University Of Louisville Research Foundation, Inc. Therapie anticancereuse dans laquelle il est fait appel a du beta glucane et a des anticorps
JP2009528267A (ja) 2006-01-17 2009-08-06 スローン − ケッタリング インスティチュート フォー キャンサー リサーチ 治療を増強するグルカン
WO2010096466A2 (fr) * 2009-02-17 2010-08-26 Novelmed Therapeutics, Inc. Procédés et compositions d'inhibition de la prolifération cellulaire et de l'adhésion chirurgicale
US20130178437A1 (en) 2010-07-09 2013-07-11 Fresenius Kabi Deutschland Gmbh Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation
LT2809329T (lt) * 2012-01-30 2018-12-10 Fresenius Kabi Deutschland Gmbh Hidroksialkilo krakmolas derinyje su citostatikais, skirti vėžio gydymui, simažinant naviko augimo greičius

Also Published As

Publication number Publication date
AU2014298637B2 (en) 2019-03-21
AU2014298637A1 (en) 2016-02-25
MX348932B (es) 2017-07-04
EP3027196B1 (fr) 2017-03-15
HRP20170877T1 (hr) 2017-09-22
WO2015014730A1 (fr) 2015-02-05
EP3027196A1 (fr) 2016-06-08
WO2015014730A4 (fr) 2015-04-09
EP3202408A2 (fr) 2017-08-09
SI3027196T1 (sl) 2017-07-31
LT3027196T (lt) 2017-06-26
HUE032564T2 (en) 2017-09-28
KR20160044493A (ko) 2016-04-25
KR20190092615A (ko) 2019-08-07
PT3027196T (pt) 2017-06-26
DK3027196T3 (en) 2017-06-26
EP3202408A3 (fr) 2017-09-20
PL3027196T3 (pl) 2017-09-29
HK1225615B (zh) 2017-09-15
US20160175340A1 (en) 2016-06-23
ES2628207T3 (es) 2017-08-02
RS56062B1 (sr) 2017-10-31
CN105555280A (zh) 2016-05-04
EP2832360A1 (fr) 2015-02-04
MX2016001259A (es) 2016-07-21
CA2918180A1 (fr) 2015-02-05

Similar Documents

Publication Publication Date Title
HRP20181566T1 (hr) Biomarkeri raka i njihove uporabe
EP2989214A4 (fr) Détermination d'interaction in situ
EP2945980A4 (fr) Agent modifiant la surface, matériaux modifiés et procédés
EP2973297A4 (fr) Techniques de découverte de contenu multimédia et d'organisation de personnage
GB201317626D0 (en) Solids in borehole fluids
GB201317311D0 (en) Account association systems and methods
GB201316673D0 (en) Account association systems and methods
EP2988742A4 (fr) Thiazoles et utilisations de ceux-ci
GB201316898D0 (en) Solids in borehole fluids
IL240248A0 (en) Met-binding substances and their uses
GB201322386D0 (en) Straight in line
HK1218518A1 (zh) 用於減少或防止轉移的組合物和方法
HRP20190538T1 (hr) Postupci i materijali za liječenje hematoloških malignosti
EP2964225A4 (fr) Inhibiteurs de camkii et leurs utilisations
GB2515754B (en) Piece for use in the construction industry and method for the manufacturing thereof
GB201411429D0 (en) Methods for monitoring treatment response and relapse in ovarian cancer
GB201320992D0 (en) Complex and uses thereof
EP2943794A4 (fr) Biomarqueurs du cancer, méthodes et systèmes associés
GB201322892D0 (en) Surface and composition
GB2510439B (en) Character animation with audio
HRP20170877T1 (hr) Polisaharid za uporabu za sprječavanje nastanka metastaza i/ili povratka bolesti
ZA201601880B (en) Hetero-transglycosylase and uses thereof
SG11201604589SA (en) Magnetic-disk substrate and magnetic-disk
HU4488U (en) Plaster-coated and edge-protected chipboard
GB201304086D0 (en) Selective glycosidase inhibitors and uses thereof